UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 256

Sortiert nach

Haemophilia care in China: Achievements in the past decade

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-09, Vol.26 (5), p.759-767

2020

Link zum Volltext

Verfügbarkeit prüfen

Desmopressin (DDAVP) use in patients with von Willebrand disease: A single‐centre retrospective review of test response and clinical outcomes

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-07, Vol.29 (4), p.1095-1103

2023

Link zum Volltext

Verfügbarkeit prüfen

Current status of haemophilia inhibitor management in mainland China: a haemophilia treatment centres survey on treatment preferences and real‐world clinical practices

British journal of haematology, 2021-08, Vol.194 (4), p.750-758

2021

Link zum Volltext

Verfügbarkeit prüfen

Patients with haemophilia A with inhibitors in China: a national real‐world analysis and follow‐up

British journal of haematology, 2021-03, Vol.192 (5), p.900-908

2021

Link zum Volltext

Verfügbarkeit prüfen

Severe haemophilia A children on low‐dose tertiary prophylaxis showed less joint deterioration and better maintenance of functional independence than children on on‐demand treatment: A 6‐year follow‐up study

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-09, Vol.26 (5), p.779-785

2020

Link zum Volltext

Verfügbarkeit prüfen

Demographics, clinical profile and treatment landscape of patients with haemophilia B in China

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-03, Vol.28 (2), p.e56-e60

2022

Link zum Volltext

Verfügbarkeit prüfen

Surgery in mild haemophilia A patients with a history of inhibitor antibodies against factor VIII: Individualized management

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-11, Vol.27 (6), p.e768-e771

2021

Link zum Volltext

Verfügbarkeit prüfen

Eradication of FIX inhibitor in haemophilia B children using low‐dose immune tolerance induction with rituximab‐based immunosuppressive agent(s) in China

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-07, Vol.28 (4), p.625-632

2022

Link zum Volltext

Verfügbarkeit prüfen

The Function of extravascular coagulation factor IX in haemostasis

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-05, Vol.27 (3), p.332-339

2021

Link zum Volltext

Verfügbarkeit prüfen

Management of haemophilia patients in the COVID‐19 pandemic: Experience in Wuhan and Tianjin, two differently affected cities in China

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-11, Vol.26 (6), p.1031-1037

2020

Link zum Volltext

Verfügbarkeit prüfen

Healthcare professionals in the ‘tainted blood’ era in Canada: Their forgotten emotions

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-07, Vol.25 (4), p.651-655

2019

Link zum Volltext

Verfügbarkeit prüfen

Poor Prognosis in Warfarin-Associated Intracranial Hemorrhage Despite Anticoagulation Reversal

Stroke (1970), 2012-07, Vol.43 (7), p.1812-1817

2012

Link zum Volltext

Verfügbarkeit prüfen

Nephrotic syndrome in two haemophilia B children with inhibitor under low‐dose immune tolerance induction combined with rituximab‐based immunosuppressant protocol

Haemophilia : the official journal of the World Federation of Hemophilia, 2022-03, Vol.28 (2), p.e42-e45

2022

Link zum Volltext

Verfügbarkeit prüfen

Factor IX inhibitors in haemophilia B: A report of National Haemophilia Registry in China

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-01, Vol.29 (1), p.123-134

2023

Link zum Volltext

Verfügbarkeit prüfen

Long‐term joint outcomes of regular low‐dose prophylaxis in Chinese children with severe haemophilia A

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-03, Vol.27 (2), p.237-244

2021

Link zum Volltext

Verfügbarkeit prüfen

Women and girls with haemophilia: A retrospective cohort study in China

Haemophilia : the official journal of the World Federation of Hemophilia, 2023-03, Vol.29 (2), p.578-590

2023

Link zum Volltext

Verfügbarkeit prüfen

Factor product utilization and health outcomes in patients with haemophilia A and B on extended half‐life concentrates: A Canadian observational study of real‐world outcomes

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-09, Vol.27 (5), p.751-759

2021

Link zum Volltext

Verfügbarkeit prüfen

A low‐dose immune tolerance induction (ITI) protocol incorporating immunosuppressive agents in haemophilia A children with high‐titre factor VIII inhibitor and poor‐ITI prognostic risk

Haemophilia : the official journal of the World Federation of Hemophilia, 2021-07, Vol.27 (4), p.e469-e472

2021

Link zum Volltext

Verfügbarkeit prüfen

Samuel Armstrong Lane's first successful treatment of haemophilia with blood transfusion in 1840: Could this also be the first successful bypassing therapy?

Haemophilia : the official journal of the World Federation of Hemophilia, 2019-01, Vol.25 (1), p.e45-e47

2019

Link zum Volltext

Verfügbarkeit prüfen

Bleeding assessment in haemophilia carriers—High rates of bleeding after surgical abortion and intrauterine device placement: A multicentre study in China

Haemophilia : the official journal of the World Federation of Hemophilia, 2020-01, Vol.26 (1), p.122-128

2020

Link zum Volltext

Verfügbarkeit prüfen

Desmopressin in non‐severe haemophilia A: Test‐response and clinical outcomes in a single Canadian centre review

Haemophilia : the official journal of the World Federation of Hemophilia, 2018-09, Vol.24 (5), p.720-725

2018

Link zum Volltext

Verfügbarkeit prüfen

Thrombosis in Inherited Fibrinogen Disorders

Transfusion medicine and hemotherapy, 2017-04, Vol.44 (2), p.70-76

2017

Link zum Volltext

Verfügbarkeit prüfen

The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention

Haematologica (Roma), 2015-08, Vol.100 (8), p.1038

2015

Link zum Volltext

Verfügbarkeit prüfen

Reduced doses of emicizumab achieve good efficacy: Results from a national‐wide multicentre real‐world study in China

Haemophilia : the official journal of the World Federation of Hemophilia, 2024-07, Vol.30 (4), p.959-969

2024

Link zum Volltext

Verfügbarkeit prüfen

The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia

Haematologica (Roma), 2015-08, Vol.100 (8), p.1031

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 256

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(220)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(160)
Life Sciences & Biomedicine
(157)
Humans
(145)
Hematology
(93)
Male
(72)
Biological And Medical Sciences
(62)
Female
(61)
Medical Sciences
(57)
Adult
(40)
Middle Aged
(35)
Hemophilia
(34)
Hematologic And Hematopoietic Diseases
(32)
Child
(28)
Adolescent
(26)
Animals
(22)
Cardiovascular System & Cardiology
(21)
General & Internal Medicine
(21)
Medicine, General & Internal
(20)
Peripheral Vascular Disease
(19)
Platelet Diseases And Coagulopathies
(19)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Haemophilia care in China: Achievements in the past decade

Desmopressin (DDAVP) use in patients with von Willebrand disease: A single‐centre retrospective review of test response and clinical outcomes

Current status of haemophilia inhibitor management in mainland China: a haemophilia treatment centres survey on treatment preferences and real‐world clinical practices

Patients with haemophilia A with inhibitors in China: a national real‐world analysis and follow‐up

Severe haemophilia A children on low‐dose tertiary prophylaxis showed less joint deterioration and better maintenance of functional independence than children on on‐demand treatment: A 6‐year follow‐up study

Demographics, clinical profile and treatment landscape of patients with haemophilia B in China

Surgery in mild haemophilia A patients with a history of inhibitor antibodies against factor VIII: Individualized management

Eradication of FIX inhibitor in haemophilia B children using low‐dose immune tolerance induction with rituximab‐based immunosuppressive agent(s) in China

The Function of extravascular coagulation factor IX in haemostasis

Management of haemophilia patients in the COVID‐19 pandemic: Experience in Wuhan and Tianjin, two differently affected cities in China

Healthcare professionals in the ‘tainted blood’ era in Canada: Their forgotten emotions

Poor Prognosis in Warfarin-Associated Intracranial Hemorrhage Despite Anticoagulation Reversal

Nephrotic syndrome in two haemophilia B children with inhibitor under low‐dose immune tolerance induction combined with rituximab‐based immunosuppressant protocol

Factor IX inhibitors in haemophilia B: A report of National Haemophilia Registry in China

Long‐term joint outcomes of regular low‐dose prophylaxis in Chinese children with severe haemophilia A

Women and girls with haemophilia: A retrospective cohort study in China

Factor product utilization and health outcomes in patients with haemophilia A and B on extended half‐life concentrates: A Canadian observational study of real‐world outcomes

A low‐dose immune tolerance induction (ITI) protocol incorporating immunosuppressive agents in haemophilia A children with high‐titre factor VIII inhibitor and poor‐ITI prognostic risk

Samuel Armstrong Lane's first successful treatment of haemophilia with blood transfusion in 1840: Could this also be the first successful bypassing therapy?

Bleeding assessment in haemophilia carriers—High rates of bleeding after surgical abortion and intrauterine device placement: A multicentre study in China

Desmopressin in non‐severe haemophilia A: Test‐response and clinical outcomes in a single Canadian centre review

Thrombosis in Inherited Fibrinogen Disorders

The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention

Reduced doses of emicizumab achieve good efficacy: Results from a national‐wide multicentre real‐world study in China

The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia

Suchergebnisse filtern